Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Khaja Moinuddin Shaik, Bhaskar Sarmah, Gaurav Suresh Wadekar & Pramod Kumar. (2022) Regulatory Updates and Analytical Methodologies for Nitrosamine Impurities Detection in Sartans, Ranitidine, Nizatidine, and Metformin along with Sample Preparation Techniques. Critical Reviews in Analytical Chemistry 52:1, pages 53-71.
Read now
Read now
Articles from other publishers (10)
Bahareh Haji Ali, Milad Shirvaliloo, Sonia Fathi‐Karkan, Shekoufeh Mirinejad, Fulden Ulucan‐Karnak, Saman Sargazi, Sara Sargazi, Roghayeh Sheervalilou & Mohammed M. Rahman. (2023) Nanotechnology‐Based Strategies for Extended‐Release Delivery of Angiotensin Receptor Blockers (ARBs): A Comprehensive Review. Chemistry & Biodiversity 20:11.
Crossref
Crossref
Abbas Mohtashamian, Alireza Soleimani, Hamid Reza Gilasi, Nejat Kheiripour, Seyed Masoud Moeini Taba & Nasrin Sharifi. (2022) Association of Zinc Status with Matrix Metalloproteinases, Advanced Glycation End-Products, and Blood Pressure in Patients with Chronic Kidney Disease. Biological Trace Element Research 201:9, pages 4275-4285.
Crossref
Crossref
Tomasz Stompór, Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, Michał Nowicki, Leszek Tylicki, Agata Winiarska & Magdalena Krajewska. (2023) Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology. Journal of Clinical Medicine 12:16, pages 5184.
Crossref
Crossref
Ashish Dash, Bikash R Meher, Biswa M Padhy, Rashmi R Mohanty & Amruta Tripathy. (2023) Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial. Cureus.
Crossref
Crossref
Aida Mary Abreu Diaz, Zalua Rodriguez Riera, Yanick Lee, Luis Miguel Esteves, Charles‐Olivier Normandeau, Baptiste Fezas, Alejandro Hernandez Saiz, François Tournoux, Daniel Juneau & Jean N. DaSilva. (2023)
[
18
F]Fluoropyridine‐losartan: A new approach toward human Positron Emission Tomography imaging of Angiotensin II Type 1 receptors
. Journal of Labelled Compounds and Radiopharmaceuticals 66:3, pages 73-85.
Crossref
Crossref
Hidekatsu Yanai, Hisayuki Katsuyama, Mariko Hakoshima & Hiroki Adachi. (2023) Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study. Biomedicines 11:2, pages 567.
Crossref
Crossref
欢 李. (2023) Research Progress in Treatment of Diabetic Proteinuria. Advances in Clinical Medicine 13:02, pages 1252-1260.
Crossref
Crossref
Adel E. Berbari, Najla A. Daouk & Majida M. Daouk. 2023. Blood Pressure Disorders in Diabetes Mellitus. Blood Pressure Disorders in Diabetes Mellitus
407
419
.
Maria Rosaria De Luca, Daniela Sorriento, Domenico Massa, Valeria Valente, Federica De Luise, Emanuele Barbato & Carmine Morisco. (2021) Effects of inhibition of the renin-angiotensin system on hypertension-induced target organ damage: clinical and experimental evidence. Monaldi Archives for Chest Disease 91:1.
Crossref
Crossref
Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Kazuyoshi Sato, Masaaki Miyakawa, Kouichi Tamura & Akira Kanamori. (2021) Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan. Journal of Diabetes Investigation.
Crossref
Crossref